Based on receptor IHC classifications, the majority of all cancers were hormonal receptor-positive, HER2-negative cancers (27 of 38, or 71%) and almost two-thirds of the cancers (23 of 38, or 61%) were of grade I or II (Table 1). The gene discussed is ERBB2; the disease is cancer.